Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16521084rdf:typepubmed:Citationlld:pubmed
pubmed-article:16521084lifeskim:mentionsumls-concept:C0035647lld:lifeskim
pubmed-article:16521084lifeskim:mentionsumls-concept:C0023688lld:lifeskim
pubmed-article:16521084lifeskim:mentionsumls-concept:C0008550lld:lifeskim
pubmed-article:16521084lifeskim:mentionsumls-concept:C0449830lld:lifeskim
pubmed-article:16521084lifeskim:mentionsumls-concept:C0205344lld:lifeskim
pubmed-article:16521084lifeskim:mentionsumls-concept:C2827597lld:lifeskim
pubmed-article:16521084pubmed:issue4lld:pubmed
pubmed-article:16521084pubmed:dateCreated2006-3-27lld:pubmed
pubmed-article:16521084pubmed:abstractTextWe describe the preparation of racemic N,N-dimethyl-3-(naphthalen-2-yl)-butan-1-amines, potential sigma1 ligands, and their resolution via chiral HPLC. In order to obtain enantiopure compounds, direct chromatographic methods of separation using chiral stationary phases were investigated. Different methods suitable for both analytical and semipreparative purposes are proposed. The best resolutions were achieved using cellulose tris (3,5-dimethylphenyl carbamate) (Chiralcel OD and OD-H) and amylose tris (3,5-dimethylphenyl carbamate) (Chiralpak AD). On the basis of the preliminary chromatographic results, the resolution of compound 1 was transferred onto a Chiralcel OD semipreparative column. The enantiomers were obtained in high enantiomeric excess. The configurational assignment was performed by circular dichroism. Computational analysis was used to explore the enantioselective recognition process of compound 1 with the Chiralcel OD stationary phase.lld:pubmed
pubmed-article:16521084pubmed:languageenglld:pubmed
pubmed-article:16521084pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16521084pubmed:citationSubsetIMlld:pubmed
pubmed-article:16521084pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16521084pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16521084pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16521084pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16521084pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16521084pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16521084pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16521084pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16521084pubmed:statusMEDLINElld:pubmed
pubmed-article:16521084pubmed:monthMaylld:pubmed
pubmed-article:16521084pubmed:issn0899-0042lld:pubmed
pubmed-article:16521084pubmed:authorpubmed-author:CollinaSimona...lld:pubmed
pubmed-article:16521084pubmed:authorpubmed-author:AlcaroStefano...lld:pubmed
pubmed-article:16521084pubmed:authorpubmed-author:RossiDanielaDlld:pubmed
pubmed-article:16521084pubmed:authorpubmed-author:GallelliAndre...lld:pubmed
pubmed-article:16521084pubmed:authorpubmed-author:MamoloMaria...lld:pubmed
pubmed-article:16521084pubmed:authorpubmed-author:ZampieriDanie...lld:pubmed
pubmed-article:16521084pubmed:authorpubmed-author:AzzolinaOrnel...lld:pubmed
pubmed-article:16521084pubmed:authorpubmed-author:LoddoGuyaGlld:pubmed
pubmed-article:16521084pubmed:authorpubmed-author:UrbanoMariang...lld:pubmed
pubmed-article:16521084pubmed:copyrightInfo2006 Wiley-Liss, Inc.lld:pubmed
pubmed-article:16521084pubmed:issnTypePrintlld:pubmed
pubmed-article:16521084pubmed:day5lld:pubmed
pubmed-article:16521084pubmed:volume18lld:pubmed
pubmed-article:16521084pubmed:ownerNLMlld:pubmed
pubmed-article:16521084pubmed:authorsCompleteYlld:pubmed
pubmed-article:16521084pubmed:pagination245-53lld:pubmed
pubmed-article:16521084pubmed:meshHeadingpubmed-meshheading:16521084...lld:pubmed
pubmed-article:16521084pubmed:meshHeadingpubmed-meshheading:16521084...lld:pubmed
pubmed-article:16521084pubmed:meshHeadingpubmed-meshheading:16521084...lld:pubmed
pubmed-article:16521084pubmed:meshHeadingpubmed-meshheading:16521084...lld:pubmed
pubmed-article:16521084pubmed:meshHeadingpubmed-meshheading:16521084...lld:pubmed
pubmed-article:16521084pubmed:meshHeadingpubmed-meshheading:16521084...lld:pubmed
pubmed-article:16521084pubmed:meshHeadingpubmed-meshheading:16521084...lld:pubmed
pubmed-article:16521084pubmed:meshHeadingpubmed-meshheading:16521084...lld:pubmed
pubmed-article:16521084pubmed:meshHeadingpubmed-meshheading:16521084...lld:pubmed
pubmed-article:16521084pubmed:meshHeadingpubmed-meshheading:16521084...lld:pubmed
pubmed-article:16521084pubmed:meshHeadingpubmed-meshheading:16521084...lld:pubmed
pubmed-article:16521084pubmed:year2006lld:pubmed
pubmed-article:16521084pubmed:articleTitleEnantioselective chromatography and absolute configuration of N,N-dimethyl-3-(naphthalen-2-yl)-butan-1-amines: potential sigma1 ligands.lld:pubmed
pubmed-article:16521084pubmed:affiliationDipartimento di Chimica Farmaceutica, Università di Pavia, Pavia, Italy.lld:pubmed
pubmed-article:16521084pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16521084pubmed:publicationTypeComparative Studylld:pubmed